BC Cancer - Surrey

13750 96th Avenue
Surrey, BC, V3V 1Z2

Clinical Trial Unit Manager
Nicole Valade
604-319-8067
nicole.valade@bccancer.bc.ca

Lung

A Phase III Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant MEDI4736 In Completely Resected Non-Small Cell Lung Cancer

A Phase II Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer

A Randomized Trial of Durvalumab (MEDI4736) and Tremelimumab +/- Platinum Based Chemotherapy in Patients with Metastatic (Stage IV) Squamous or Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects With Extensive Stage Small Cell Lung Cancer (MERU)

INSIGNA : A Randomized, Phase III Study of Firstline Immunotherapy Alone or in Combination With Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) With Immunobiomarker SIGNature-Driven Analysis

Cancer Type
Lung
Phase III
Recruiting Dates
BC Cancer - Vancouver
Open Recruiting Date
BC Cancer - Surrey
Open Recruiting Date
View on ClinicalTrials.gov

SKYSCRAPER-03: A Phase III, Open-Label Randomized Study of Atezolizumab and Tiragolumab Compared with Durvalumab in Patients With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer who Have Not Progressed After Concurrent Platinum-Based Chemoradiation 

Cancer Type
Lung
Phase III
Recruiting Dates
BC Cancer - Victoria
Open Recruiting Date
BC Cancer - Abbotsford
Open Recruiting Date
BC Cancer - Surrey
Open Recruiting Date
View on ClinicalTrials.gov
Back to top